日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Association between treatment-emergent cytopenias and clinical responses to imetelstat in lower-risk myelodysplastic syndromes

低危骨髓增生异常综合征患者治疗期间出现的血细胞减少症与伊美替司他临床疗效之间的关联

Zeidan, Amer M; Santini, Valeria; Díez-Campelo, María; Savona, Michael R; Sekeres, Mikkael A; Madanat, Yazan F; Fenaux, Pierre; Raza, Azra; Mittelman, Moshe; Thépot, Sylvain; Buckstein, Rena; Germing, Ulrich; Valcárcel, David; Jonášová, Anna; Shah, Sheetal; Xia, Qi; Sun, Libo; Navada, Shyamala; Berry, Tymara; Platzbecker, Uwe; Komrokji, Rami S

Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents

结合突变和细胞遗传学特征的急性髓系白血病预后模型(采用维奈托克和去甲基化药物治疗)

Drekolias, Dimitrios; Tuz Zahra, Fatima; Fileni, Caroline; Sallman, David A; Mo, Qianxing; Chan, Onyee; Zhang, Ling; Vincelette, Nicole D; Yu, Xiaoqing; Sammut, Rinzine; Moon, Jungwon; Park, Junyoung; Umasangtongkul, Sura-Attha; Lledo, Felyschia M; Razabdouski, Tiffany N; Cheng, Chia-Ho; Qin, Dahui; Mai, Kathy; Ball, Somedeb; Shallis, Rory M; Xie, Zhuoer; Kuykendall, Andrew T; Padron, Eric; Sweet, Kendra; Walker, Alison R; Komrokji, Rami S; Lancet, Jeffrey E; Niyongere, Sandrine; Cluzeau, Thomas; Yun, Seongseok

Neuraxial versus general anesthesia for primary total knee arthroplasty: A retrospective analysis comparing postoperative outcomes and rates of complications

椎管内麻醉与全身麻醉在初次全膝关节置换术中的应用:一项回顾性分析比较术后结果和并发症发生率

Beydoun, Rami S; Hefelfinger, Donald C; Wright, David P; Auch, Elijah; Haley, Henry R; Sareini, Mohamed-Ali; Moore, Drew D; Karadsheh, Mark

Neuraxial versus general anesthesia for primary total hip arthroplasty: A retrospective analysis comparing postoperative outcomes and rates of complications

椎管内麻醉与全身麻醉在初次全髋关节置换术中的应用:一项回顾性分析比较术后结果和并发症发生率

Sareini, Mohamed-Ali; Beydoun, Rami S; Hefelfinger, Donald C; Wright, David P; Auch, Elijah; Moore, Drew D; Karadsheh, Mark

Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement

降低MDS患者参与临床试验的门槛:icMDS立场声明

Borate, Uma; Pugh, Kelly; Waller, Allyson; Welkie, Rina Li; Huang, Ying; Bewersdorf, Jan Philipp; Stahl, Maximilian; DeZern, Amy E; Platzbecker, Uwe; Sekeres, Mikkael A; Wei, Andrew H; Buckstein, Rena J; Roboz, Gail J; Savona, Michael R; Loghavi, Sanam; Hasserjian, Robert P; Fenaux, Pierre; Sallman, David A; Hourigan, Christopher S; Della Porta, Matteo Giovanni; Nimer, Stephen; Little, Richard F; Santini, Valeria; Efficace, Fabio; Taylor, Justin; Garcia-Manero, Guillermo; Odenike, Olatoyosi; Kim, Tae Kon; Halene, Stephanie; Komrokji, Rami S; Griffiths, Elizabeth A; Greenberg, Peter L; Xu, Mina L; Xie, Zhuoer; Bejar, Rafael; Sanz, Guillermo F; Patnaik, Mrinal M; Figueroa, Maria; Carraway, Hetty E; Abdel-Wahab, Omar; Starczynowski, Daniel; Padron, Eric; Boultwood, Jacqueline; Gore, Steven; Daver, Naval G; Churpek, Jane E; Majeti, Ravindra; Bennett, John M; List, Alan F; Brunner, Andrew M; Zeidan, Amer M

Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML

长期随访及eprenetapopt联合阿扎胞苷治疗TP53突变型MDS/AML患者的II期联合试验结果

Sallman, David A; Komrokji, Rami S; Dezern, Amy E; Sebert, Marie; Garcia-Manero, Guillermo; Rahmé, Ramy; Winer, Eric S; Lehmann-Che, Jacqueline; Roboz, Gail J; Madelaine, Isabelle; Sekeres, Mikkael A; Peterlin, Pierre; Chan, Onyee; Beyne-Rauzy, Odile; Kuykendall, Andrew; Recher, Christian; McLemore, Amy; Stamatoullas, Aspasia; Zhang, Ling; Willems, Lise; Mo, Qianxing; Raffoux, Emmanuel; Nardelli, Lisa; Berthon, Céline; Al Ali, Najla H; Quesnel, Bruno; Padron, Eric; Kantarjian, Hagop M; List, Alan F; Ades, Lionel; Lancet, Jeffrey E; Fenaux, Pierre; Cluzeau, Thomas

Response to luspatercept can be predicted and improves overall survival in the real-life treatment of LR-MDS

在真实世界中,对鲁帕西普的反应可以预测,并且能够改善低危骨髓增生异常综合征(LR-MDS)患者的总体生存期。

Consagra, Angela; Lanino, Luca; Al Ali, Najla H; Aguirre, Luis; Xie, Zhuoer; Chan, Onyee; Andreossi, Gloria; Raddi, Marco G; Rigodanza, Luca; Sanna, Alessandro; Mattiuz, Giorgio; Tofacchi, Elena; Amato, Cristina; Tanturli, Michele; De Pourcq, Sven; Walker, Alison; Kuykendall, Andrew; Lancet, Jeffrey; Padron, Eric; Sallman, David A; Restuccia, Francesco; Perego, Alessandra; Ubezio, Marta; Fattizzo, Bruno; Riva, Marta; Maggioni, Giulia; Campagna, Alessia; Della Porta, Matteo G; Santini, Valeria; Komrokji, Rami S

Effect of prior therapy on the clinical activity of imetelstat in patients with transfusion-dependent, ESA-relapsed or -refractory/-ineligible LR-MDS

既往治疗对输血依赖型、ESA复发或难治/不适合接受ESA治疗的低危骨髓增生异常综合征(LR-MDS)患者使用伊美替司他(imetelstat)临床疗效的影响

Komrokji, Rami S; Santini, Valeria; Zeidan, Amer M; Sekeres, Mikkael A; Fenaux, Pierre; Raza, Azra; Mittelman, Moshe; Thépot, Sylvain; Buckstein, Rena; Germing, Ulrich; Madanat, Yazan F; Díez-Campelo, María; Valcárcel, David; Jonášová, Anna; Dougherty, Souria; Shah, Sheetal; Xia, Qi; Sun, Libo; Navada, Shyamala; Feller, Faye; Savona, Michael R; Platzbecker, Uwe

Spatial biomarkers of response to eribulin plus pembrolizumab in patients with metastatic triple negative breast cancer in the ENHANCE-1 trial.

ENHANCE-1 试验中转移性三阴性乳腺癌患者对艾立布林加帕博利珠单抗治疗反应的空间生物标志物

Foong Yee Hoon, Wang Qi, Kearney Matthew, Le Hortense, Guo Hua, Chen Diane, Politis Michelle Garlin, Connelly Courtney F, Kalinsky Kevin, Vanguri Rami S, Connolly Eileen P

Prevention and Reversal of Hypertension-Induced Coronary Microvascular Dysfunction by a Plant-Based Diet.

植物性饮食预防和逆转高血压引起的冠状动脉微血管功能障碍。

Najjar Rami S, Hekmatyar Nedumangalam, Wang Yanling, Ngo Vu, Lail Hannah L, Tejada Juan P, Danh Jessica P, Wanders Desiree, Feresin Rafaela G, Mehta Puja K, Gewirtz Andrew T